Melody Smith, MD

About Me

I am a board-certified medical oncologist and hematologist and I work as part of a multidisciplinary team caring for people with hematologic disorders. I have a special interest and expertise in treating patients using immunotherapy and stem cell transplantation to treat blood disorders. I am also involved in laboratory and clinical research employing chimeric antigen receptor T cells targeting CD19 (CD19 CAR T cells) in the post-transplant setting in order to improve transplant outcomes. 

  • Clinical Expertise: Hematologic Malignancies; Immunotherapy; Blood & Marrow Stem Cell Transplantation
  • Languages Spoken: English; Spanish
  • Education: MD with Distinction in Research, University of Texas Southwestern Medical School
  • Residencies: University of Texas Southwestern Medical Center
  • Fellowships: Memorial Sloan Kettering Cancer Center
  • Board Certifications: Internal Medicine; Medical Oncology

See My Colleagues


Visit PubMed for a full listing of Melody Smith’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.